by jlohrconsulting | Sep 30, 2025 | Uncategorized
J Yeungnam Med Sci. 2025;42:61. doi: 10.12701/jyms.2025.42.61. Epub 2025 Sep 29. ABSTRACT Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed for type 2 diabetes mellitus and obesity, are increasingly recognized for their significant impact on...
by jlohrconsulting | Sep 30, 2025 | Uncategorized
J Eat Disord. 2025 Sep 29;13(1):217. doi: 10.1186/s40337-025-01399-4. ABSTRACT BACKGROUND: Many children and young people presenting with anorexia nervosa will also be autistic. While autistic children and young people may have similar physical health outcomes...
by jlohrconsulting | Sep 30, 2025 | Uncategorized
Cureus. 2025 Aug 29;17(8):e91225. doi: 10.7759/cureus.91225. eCollection 2025 Aug. ABSTRACT We present a case of anorexia nervosa (AN), which is a rare cause of hypercortisolism. We discuss the case of a female patient with a body mass index (BMI) of 12.4 kg/m2 who...
by jlohrconsulting | Sep 30, 2025 | Uncategorized
Sci Data. 2025 Sep 29;12(1):1577. doi: 10.1038/s41597-025-05817-9. ABSTRACT The global surge in depression rates, notably severe in China with over 95 million affected, underscores a dire public health issue. This is exacerbated by a critical shortfall in mental...
by jlohrconsulting | Sep 30, 2025 | Uncategorized
Sci Rep. 2025 Sep 29;15(1):33647. doi: 10.1038/s41598-025-14866-4. ABSTRACT Vortioxetine is a multimodal antidepressant with reported benefits on cognitive functioning, social functioning, and fatigue, however its potential genotoxic risks have not been adequately...
by jlohrconsulting | Sep 30, 2025 | Uncategorized
Sci Rep. 2025 Sep 29;15(1):33478. doi: 10.1038/s41598-025-14648-y. ABSTRACT The global prevalence of depression continues to rise, making it a leading cause of suicide. Although evidence-based treatments for mental disorders exist, over 75% of affected individuals in...
Recent Comments